Event Type
Disclosure
Mandatory
Variant
8-K
. Submission of Matters to a Vote of Security Holders. On December 8, 2025, Lixte Biotechnology Holdings, Inc. (the “Company”), held its Annual Meeting. At the
Financial Statements and Exhibits (d) Exhibits. The following exhibits are filed herewith. Exhibit Number Description 10.1 Amendment to the Lixte Biotechnology